共 50 条
LINKAGE STUDIES IN PROGRESSIVE MYOCLONUS EPILEPSY - UNVERRICHT-LUNDBORG AND LAFORAS DISEASES
被引:52
作者:
LEHESJOKI, AE
KOSKINIEMI, M
PANDOLFO, M
ANTONELLI, A
KYLLERMAN, M
WAHLSTROM, J
NERGARDH, A
BURMEISTER, M
SISTONEN, P
NORIO, R
DELACHAPELLE, A
机构:
[1] UNIV HELSINKI,DEPT VIROL,SF-00290 HELSINKI 29,FINLAND
[2] FOLKHALSAN INST GENET,HELSINKI,FINLAND
[3] IST NEUROCHIRURG C BESTA,DIV BIOCHIM & GENET SISTEMA NERVOSO,I-20133 MILAN,ITALY
[4] OSTRA HOSP,DEPT PEDIAT 2,GOTHENBURG,SWEDEN
[5] OSTRA HOSP,DEPT PEDIAT,GOTHENBURG,SWEDEN
[6] KAROLINSKA HOSP,DEPT PEDIAT,S-10401 STOCKHOLM 60,SWEDEN
[7] UNIV MICHIGAN,MENTAL HLTH RES INST,ANN ARBOR,MI 48109
[8] FINNISH RED CROSS & BLOOD TRANSFUS SERV,HELSINKI,FINLAND
[9] FINNISH POPULAT & FAMILY WELF FEDERAT,DEPT MED GENET,HELSINKI,FINLAND
来源:
关键词:
D O I:
10.1212/WNL.42.8.1545
中图分类号:
R74 [神经病学与精神病学];
学科分类号:
摘要:
The progressive myoclonus epilepsies (PME) are a heterogeneous group of rare genetic disorders. Unverricht-Lundborg disease and Lafora's disease are two major classic forms of PME. We recently assigned the gene for Unverricht-Lundborg disease (EPM1) to human chromosome 21 band q22.3. We have now refined the localization of EPM1 by linkage analysis between the disease phenotype and nine DNA markers in 13 Finnish families. Loci MX1 and CD18 flank the EPM1 interval, which spans a distance of about 3.5 megabases. In this 20-centimorgan interval, no recombinations were detected between EPM1 and marker loci BCEI, D21S19, D21S42, D21S113, D21S154, and PFKL. Within this interval a maximum multipoint lod score of 11.04 was reached at loci D21S154-PFKL. In two Swedish families with Unverricht-Lundborg disease no recombinations were detected. In three Italian families with Lafora's disease the linkage results suggested that EPM1 is not the locus for Lafora's disease.
引用
收藏
页码:1545 / 1550
页数:6
相关论文
共 50 条